百济神州

全球以研发为基础的生物制药公司

北京 2000人以上 医疗/健康/制药/生物 未融资

企业介绍

BeiGene, Ltd. (NASDAQ: BGNE) is a global,commercial-stage, research-based biotechnology company focused on molecularlytargeted and immuno-oncology cancer therapeutics. With a team of over 2200 employeesin China, the United States (Cambridge, MA, Fort Lee, NJ, Emeryville, CA &San Mateo, CA), and Australia, BeiGene is advancing a pipeline consisting ofnovel oral small molecules and monoclonal antibodies for the treatment ofcancer. BeiGene is working to create combination solutions aimed at having botha meaningful and lasting impact on cancer patients.  

企业资料
百济神州(北京)生物科技有限公司
工商信息
公司类型:有限责任公司(台港澳法人独资)
统一社会信用代码:91110114567400208U
成立日期:2011-01-24
注册资本:4671.1万美元
投递
客服